Epizyme Announces FDA Filing Acceptance of New Drug Application and Priority Review for Tazemetostat for the Treatment of Epithelioid Sarcoma Read more
CEPI awards up to US$23.4 million to Valneva for late-stage development of a single-dose Chikungunya vaccine Read more
Gemphire Therapeutics and NeuroBo Announce Merger Agreement to Advance a Neurodegenerative Disease Company Read more
Opiant Expands Partnership with Sanofi, Signs Agreement for Manufacturing OPNT004 for Treatment of Acute Cannabinoid Overdose Read more
REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases Read more
Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay Read more
Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu in Flu Care Read more